David M Rapoport

Title: David M. Rapoport and Respiratory Therapy Innovation.

Introduction

David M. Rapoport is an inventor associated with Auckland, New Zealand, and Fisher & Paykel Healthcare Limited. His patent work concerns respiratory therapy for sleep-disordered breathing, including obstructive sleep apnea and Cheyne-Stokes respiration.

Latest Patents

Rapoport is associated with 1 patent: “Method of Driving a Form of Respiratory Therapy.” The invention describes controlling a medical device by estimating a user’s carbon dioxide level through a dynamic lung model driven by observed respiration signals. The estimate can help predict breathing events such as hypopnea and apnea, allowing therapy to be adjusted or delivered through a ramp cycle to reduce their prevalence and adverse effects. The patent also describes variable ventilation therapy that raises pressure over multiple breaths and then lowers it relatively quickly, such as during expiration.

Career Highlights

Rapoport’s patent reflects an approach to respiratory care that uses modeled physiological information to anticipate breathing events and guide treatment. His work is associated with Fisher & Paykel Healthcare Limited, a company focused on medical devices and respiratory care.

Collaborations

Mark Renfrew Titchener is identified as a coworker associated with Rapoport.

Conclusion

David M. Rapoport’s patent work highlights the use of respiratory modeling and adaptive pressure delivery to support treatment for sleep-disordered breathing.